CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-17 | MORE ROBERT J Director | Sale | −11,670 | $43.95 | $513K | 69,369 |
| 2021-06-16 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $5.18 | $26K | 114,277 |
| 2021-06-16 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $43.67 | $218K | 109,277 |
| 2021-06-16 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 62,129 | ||
| 2021-06-15 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 93,075 |
| 2021-06-15 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $45.29 | $62K | 91,700 |
| 2021-06-15 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 298,755 | ||
| 2021-06-03 | MORE ROBERT J Director | Sale | −11,670 | $44.56 | $520K | 81,039 |
| 2021-06-02 | Pang Phillip Chief Medical Officer | Option exercise | +10,000 | $0.86 | $9K | 119,277 |
| 2021-06-02 | Pang Phillip Chief Medical Officer | Sale | −9,700 | $41.47 | $402K | 109,577 |
| 2021-06-02 | Pang Phillip Chief Medical Officer | Sale | −300 | $42.18 | $13K | 109,277 |
| 2021-06-02 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −10,000 | 23,833 | ||
| 2021-06-01 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 93,075 |
| 2021-06-01 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $42.51 | $58K | 91,700 |
| 2021-06-01 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 300,130 | ||
| 2021-05-21 | Sigal Charles Elliott Director | Grant or award | +3,374 | 3,374 | ||
| 2021-05-21 | Sigal Charles Elliott Director | Grant or award · Stock Option (Right to Buy) | +6,748 | 6,748 | ||
| 2021-05-21 | SHARP PHILLIP A Director | Grant or award | +3,374 | 108,742 | ||
| 2021-05-21 | SHARP PHILLIP A Director | Grant or award · Stock Option (Right to Buy) | +6,748 | 6,748 | ||
| 2021-05-21 | Ramasastry Saira Director | Grant or award | +3,374 | 3,374 |
Page 40 of 54 · 1,063 trades